Versant Capital Management, Inc Edwards Lifesciences Corp Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,698 shares of EW stock, worth $118,639. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,698
Previous 1,553
9.34%
Holding current value
$118,639
Previous $114,000
7.89%
% of portfolio
0.02%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding EW
# of Institutions
1,384Shares Held
454MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$4.83 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.56 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.8 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.04 Billion0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA13.6MShares$954 Million0.08% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $43.2B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...